"Collaboration: 23andMe Partners with GSK for Consumer DNA Data Access"

GSK will pay 23andMe $20 million for access to the genetic-testing company's consumer DNA data, allowing the drugmaker to continue mining genetic data for research purposes. 23andMe will provide GSK with one year of access to anonymized DNA data from customers who have agreed to share their information, as well as data-analysis services. With over 14 million customers, 23andMe's DNA library is one of the largest in the world.